BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.010
0.00%
(0.00) 1D
Nov 6, 4:10:28 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Mkt. cap
30.39M
Avg. vol.
9.97M
Volume
0.00
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Mkt. cap
30.39M
Avg. vol.
9.97M
Volume
0.00
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
TheStreet
·
30 minutes ago
Why S&P 500 investors may want to look beyond mega-cap tech
Binance
·
1 hour ago
TradFi News | Nasdaq Drops 3.4% in Week as AI Chip Stocks Slump; Berkshire Posts Record $9.6 Billion Buyback
IndexBox
·
1 hour ago
Capital Economics Warns AI Investment Boom Is Fading, Sees S&P 500 Falling 12% by End of 2027
Yahoo Finance
·
5 hours ago
Coca-Cola (KO) Makes the Dow’s Low-Upside List While Selling More Drinks, Not Just Charging More
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com